Items where authors include "Collette, L"

Article

Beyer, J, Collette, L, Sauvé, N et al. (38 more authors) (2021) Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium. Journal of Clinical Oncology. ISSN 0732-183X

Coens, C, Pe, M, Dueck, AC et al. (32 more authors) (2020) International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. The Lancet Oncology, 21 (2). e83-e96. ISSN 1470-2045

Schöffski, P, Wozniak, A, Stacchiotti, S et al. (20 more authors) (2019) Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’. Annals of Oncology, 30 (2). p. 344. ISSN 0923-7534

Bottomley, A, Pe, M, Sloan, J et al. (38 more authors) (2018) Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clinical Trials, 15 (6). pp. 624-630. ISSN 1740-7745

Pe, M, Dorme, L, Coens, C et al. (29 more authors) (2018) Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. The Lancet Oncology, 19 (9). E459-E469. ISSN 1470-2045

Schöffski, P, Wozniak, A, Stacchiotti, S et al. (20 more authors) (2017) Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’. Annals of Oncology, 28 (12). pp. 3000-3008. ISSN 0923-7534

Bottomley, A, Pe, M, Sloan, J et al. (36 more authors) (2016) Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncology, 17 (11). e510-e514. ISSN 1470-2045